JasonPMoranMD
Hematology • South Portland, MEHematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Hematologist/Oncologist, Maine Medical Center
Dr. Moran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
265 Western Ave Suite 2
South Portland, ME 04106Phone+1 207-661-0200Fax+1 888-368-4071
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2019- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2015
Massachusetts General HospitalInternship, Transitional Year, 2011 - 2012
Georgetown University School of MedicineClass of 2011
Certifications & Licensure
ME State Medical License 2019 - 2025
MA State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsManaging thromboembolic risk in patients with hereditary and acquired thrombophiliasJason P. Moran, Kenneth A. Bauer
Blood. 2020-01-30 - 15 citationsDe novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancersAntonio R. Lucena-Araujo, Jason P. Moran, Paul A. VanderLaan, Dora Dias-Santagata, Erik Folch
Lung Cancer. 2016-09-01 - 29 citationsPulse Afatinib for ERBB2 Exon 20 Insertion–Mutated Lung AdenocarcinomasDaniel B. Costa, Susan E. Jorge, Jason P. Moran, Jason A. Freed, Jessica A. Zerillo
Journal of Thoracic Oncology. 2016-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
